Journal
AAPS PHARMSCITECH
Volume 23, Issue 1, Pages -Publisher
SPRINGER
DOI: 10.1208/s12249-021-02146-z
Keywords
PLGA nanospheres; chitosan; trimethyl chitosan; nasal delivery; mucosal and cell-mediated responses
Categories
Funding
- Mashhad University of Medical Sciences, Mashhad, Iran [941041]
Ask authors/readers for more resources
This study aimed to evaluate the immune efficacy of multi-subunit vaccines against Mycobacterium Tuberculosis using surface-modified PLGA nanoparticles. The vaccines showed potential in stimulating cell-mediated and mucosal responses, improving protective effects, and modulating the Th1/Th2 balance.
The crucial challenge in tuberculosis (TB) as a chronic infectious disease is to present a novel vaccine candidate that improves current vaccination and provides efficient protection in individuals. The present study aimed to evaluate the immune efficacy of multi-subunit vaccines containing chitosan (CHT)- or trimethyl chitosan (TMC)-coated PLGA nanospheres to stimulate cell-mediated and mucosal responses against Mycobacterium Tuberculosis (Mtb) in an animal model. The surface-modified PLGA nanoparticles (NPs) containing tri-fusion protein from three Mtb antigens were produced by the double emulsion technique. The subcutaneously or nasally administered PLGA vaccines in the absence or presence of BCG were assessed to compare the levels of mucosal IgA, IgG1, and IgG2a production as well as secretion of IFN-gamma, IL-17, IL-4, and TGF-beta cytokines. According to the release profile, the tri-fusion encapsulated in modified PLGA NPs demonstrated a biphasic release profile including initial burst release on the first day and sustained release within 18 days. All designed PLGA vaccines induced a shift of Th1/Th2 balance toward Th1-dominant response. Although immunized mice through subcutaneous injection elicited higher cell-mediated responses relative to the nasal vaccination, the intranasally administered groups stimulated robust mucosal IgA immunity. The modified PLGA NPs using TMC cationic polymer were more efficient to elevate Th1 and mucosal responses in comparison with the CHT-coated PLGA nanospheres. Our findings highlighted that the tri-fusion loaded in TMC-PLGA NPs may represent an efficient prophylactic vaccine and can be considered as a novel candidate against TB.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available